Inhaled CpG increases survival and synergizes with checkpoint inhibition in lymphangioleiomyomatosis

RATIONALE: Lymphangioleiomyomatosis (LAM) is a devastating disease primarily found in women of reproductive age that leads to cancer-like cystic destruction of the lungs. Recent work has shown that LAM causes immunosuppression and that checkpoint inhibitors can be used as LAM treatment. IN lung canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Amosu, Mayowa M, McCright, Jacob C, Yang, Bennett E, de Oro Fernandez, Juan Grano, Moore, Kaitlyn A, Gadde, Havish S, Kaluzienski, Michele L, Maisel, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934559/
https://www.ncbi.nlm.nih.gov/pubmed/36798234
http://dx.doi.org/10.1101/2023.02.06.527331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934559/
https://www.ncbi.nlm.nih.gov/pubmed/36798234
http://dx.doi.org/10.1101/2023.02.06.527331

Ejemplares similares